Healthcare
NVM leads £2m round for Newcells Biotech
NVM provides £1.5m towards the round, while Northstar contributes the remaining £500,000
Weinberg's Pharma Omnium sells Biodim subsidiary
Apax Partners' NuPharm acquires France-based Laboratoire Biodim from its parent company
Nordic inks Prospitalia deal with Five Arrows
GP intends to support management in its plan to strengthen the company's market position
Waterland's Median buys Klinikzentrum Mühlengrund
Seventeenth bolt-on acquisition in the healthcare buy-and-build strategy since 2011
CVC buys 51.8% stake in Recordati for €3.03bn
Recordati family will receive €2.3bn in cash and €750m in subordinated long-term debt securities
Bain buys DSM Sinochem Pharmaceuticals
Bain Capital acquires DSM Sinochem Pharmaceuticals via its Bain Capital Europe IV vehicle
Novo Ventures leads CHF 20m round for NBE Therapeutics
PPF Capital Partners Fund and Boehringer Ingelheim Venture Fund (BIVF) also take part
Livingbridge sells Portman stake in SBO to Core Equity
GP sells its minority stake in the dentistry business after a four-year holding period
Principia backs CrestOptics
VC firm deployed capital from its healthcare-dedicated vehicle Principia III – Health
Sofinnova and 5AM lead £28m series-A for NodThera
UK drug discovery company will bring its leading drug candidate to the clinical trial stage
Ergon Capital buys Indo in SBO
Sale ends a five-year holding period for Sherpa, which acquired the company after it hit bankruptcy
HTGF sells Sierra Sensors to trade
Sale ends a 12-year holding period for HTGF, which invested in the business from its first fund
MPM et al. in €64m series-B for iTeos Therapeutics
Previous and new backers inject €64m in the cancer-focused biotechnology company
CVC in talks over acquisition of Recordati
Talks were put on hold recently due to concerns about Italy's political uncertainty
PE-backed SGH Healthcaring buys Rovipharm and RR Plastiques
SGH Healthcaring's double-acquisition is supported by a Bluebay financing package
Epidarex and Sixth Element in $10m round for Adorx
Cancer drug discovery company will ramp up its research activities following the round
Syncona leads £88.4m series-B for Freeline
Gene therapy company will undertake clinical trials and look to bring its therapies to market
TVP et. al in £4.4m round for Micrima
Developer of breast cancer screening systems will bring its Maria product to market
Triton acquires Unident
Unident is the fund's first investment in the healthcare sector and was led from the Nordic office
Advent gears up for launch of third life sciences fund
VC makes investments in life sciences companies based in the UK, continental Europe and the US
Advent buys Deutsche Fachpflege from Chequers
Current management team will retain a stake in the new company and remain in their positions
Invision launches sixth buyout fund
Fund was registered in Jersey on 5 December 2017 as Invision VI Limited Partnership
Nazca Capital backs Phibo
Company will use the fresh capital to increase its production capacity and boost its market position
Vitruvian buys Doctari
GP draws equity for the transaction from its €2.4bn buyout fund, Vitruvian Partnership III